A number of prescription treatments , such as copyright and Semaglutide, are part of the GLP-1 category . Mainly, these therapies work by mimicking the body's own substances that regulate blood glucose and encourage a reduction in weight . Though copyright is a brand name for managing type 2 dia

Sufferers struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide functions